Measuring glucose in vivo over the long term is challenging and difficult. Previous measurement systems were limited to acute studies or a few days at best. WPI introduces a new kind of implantable glucose sensor based on a patented technology. This sensor provides a tool for researchers to directly detect glucose in chronic studies in vitro or in vivo. The sensor is fully compatible with WPI’s Apollo system.
Our glucose sensors work with the TBR4100 and TBR1025 free radical analyzers.